Tackling challenges in epilepsy management: a practical approach
18 Mar 2021
About the event
This webinar series has been designed to present a robust learning environment for healthcare professionals; with a forty-minute presentation including live polling followed by fifteen minutes of interactive Q&A. The webinar series will cover a wide range of themes including the neurobiological basis of epilepsy; and how digital technology may improve patient care; as well as providing practical guidance on managing patient populations that are particularly challenging.
Founded in 1924, BIAL’s mission is to discover, develop and provide new therapeutic solutions within the area of Health. Today, BIAL is an innovative international pharmaceutical company with products available in more than 55 countries. The company is committed to making a contribution to improve human health and quality of life for people from all over the world.
Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), BIAL has established an ambitious R&D programme. Key focus areas for the Group are the neurosciences and cardiovascular. The Bial team currently consists of 900 workers. We bring together our knowledge, experience, imagination and dedication to achieve a concrete goal: providing high quality medicines. 79% of our workers have higher education qualifications, 7% of which are PhDs.
